Virtual event

When the Barrier to Breakthrough Medicine Is You Can’t Make It

Editor’s note: A recording of the conversation is embedded below.

DDespite all their promise, new medicines, especially those based on cutting-edge technologies, have faced unprecedented challenges in scaling up manufacturing, quality control and market launch.

Learn how the developers approached different aspects of the manufacturing process to bring new and innovative treatments to patients.

advertising

Agenda:

Introduction:

advertising

  • Alessandro MaselliPresident and CEO, Catalent (sponsor speaker)

Part 1: BioNTech’s plans to bring mRNA to the world
How to make mRNA in Africa? What are the logistical challenges of new personalized mRNA cancer vaccines? A look at BioNTech’s projects.

  • Sierk Poetting, Ph.D.Chief Operating Officer, BioNTech
  • Allison DeAngelisbiotech startups and venture capital journalist, STAT (moderator)

Part 2: BioMarin’s plans to create a new gene therapy
BioMarin’s hemophilia gene therapy, Roctavian, will present specific manufacturing challenges. The company has been investing for years to solve them.

  • C. Greg Guyer, Ph.D.Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations, BioMarin
  • Matthew Herper, Senior Editor, Medicine; Editorial Director of Events, STAT (moderator)